CSIMarket
 


Beam Therapeutics Inc   (BEAM)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

BEAM's EPS Net Growth by Quarter and Year

Beam Therapeutics Inc 's EPS Net results by quarter and year




BEAM EPS Net (in $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - -1.68 -0.01 0.71
III Quarter September - -0.69 0.54 0.79
II Quarter June - -0.69 0.52 0.47
I Quarter March -3.35 -1.03 0.46 0.62
FY   -3.35 -4.09 1.51 2.59



BEAM EPS Net first quarter 2021 Y/Y Growth Comment
Beam Therapeutics Inc in the first quarter recorded EPS net loss of $ -3.35 .

According to the results reported in the first quarter, Beam Therapeutics Inc achieved the best EPS Net growth in Biotechnology & Drugs industry. While Beam Therapeutics Inc ' s EPS Net no change of % ranks overall at the positon no. in the first quarter.




BEAM EPS Net ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - 44.9 %
III Quarter September - - -31.65 % 33.9 %
II Quarter June - - 10.64 % -82.4 %
I Quarter March - - -25.81 % -70.33 %
FY   - - -41.7 % -55.65 %

Financial Statements
Beam Therapeutics Inc 's first quarter 2021 EPS Net $ -3.35 BEAM's Income Statement
Beam Therapeutics Inc 's first quarter 2020 EPS Net $ -1.03 Quarterly BEAM's Income Statement
New: More BEAM's historic EPS Net Growth >>


BEAM EPS Net (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -10.13 %
III Quarter September - - 3.85 % 68.09 %
II Quarter June - - 13.04 % -24.19 %
I Quarter March - - -35.21 % 26.53 %
FY (Year on Year)   - - -41.7 % -55.65 %




EPS Net first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Beam Therapeutics Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BEAM's I. Quarter Q/Q EPS Net Comment
Current accomplishment of -3.35 by Beam Therapeutics Inc come out even worse compare to the -1.68 EPS net loss in the forth quarter.

Within Biotechnology & Drugs industry Beam Therapeutics Inc achieved highest sequential EPS Net growth. While Beam Therapeutics Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BEAM's I. Quarter Q/Q EPS Net Comment
I. Quarter 2021 results of -3.35 by Beam Therapeutics Inc appear even less good considering the EPS net loss -1.68 in the previous quarter.

Within Biotechnology & Drugs industry Beam Therapeutics Inc achieved highest sequential EPS Net growth. While Beam Therapeutics Inc 's EPS Net growth quarter on quarter, overall rank is .


Beam Therapeutics Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative EPS Net 12 Months Ending $ -6.41 $ -4.09 $ -2.42 $ -1.19 $ 0.02
Y / Y EPS Net Growth (TTM) - - - - -99.21 %
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -98.73 %
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Beam Therapeutics Inc realized trailing twelve months EPS net loss of $ -6 , in the Mar 31 2021, compare to EPS Net of $ 0 a year ago.

Beam Therapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Beam Therapeutics Inc realized trailing twelve months EPS net loss of $ -6 , in the Mar 31 2021, compare to EPS Net of $ 0 a year ago.

Beam Therapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Biotechnology & Drugs Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
BEAM's EPS Net Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for BEAM's Competitors
EPS Net Growth for Beam Therapeutics Inc 's Suppliers
EPS Net Growth for BEAM's Customers

You may also want to know
BEAM's Annual Growth Rates BEAM's Profitability Ratios BEAM's Asset Turnover Ratio BEAM's Dividend Growth
BEAM's Roe BEAM's Valuation Ratios BEAM's Financial Strength Ratios BEAM's Dividend Payout Ratio
BEAM's Roa BEAM's Inventory Turnover Ratio BEAM's Growth Rates BEAM's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Mar 31 2021
Integra Lifesciences Holdings Corp381.82%$ 381.818 
Quest Diagnostics Inc373.97%$ 373.973 
Quidel Corporation339.78%$ 339.785 
Progyny Inc 275.00%$ 275.000 
Abbott Laboratories222.58%$ 222.581 
Repligen Corp188.89%$ 188.889 
Meridian Bioscience Inc 172.73%$ 172.727 
Apollo Medical Holdings Inc 172.73%$ 172.727 
Iqvia Holdings Inc 159.52%$ 159.524 
Reynolds Consumer Products Inc 150.00%$ 150.000 
Hca Healthcare Inc 144.97%$ 144.970 
Diffusion Pharmaceuticals Inc 141.75%$ 141.745 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EBTC's Profile

Stock Price

EBTC's Financials

Business Description

Fundamentals

Charts & Quotes

EBTC's News

Suppliers

EBTC's Competitors

Customers & Markets

Economic Indicators

EBTC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071